Observational studyEuropean journal of pediatrics2022

Procalcitonin is a prognosis biomarker in very preterm neonates with late onset sepsis: a pilot study.

Valerie Ruetsch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.